Skip to content

A study to compare injection and oral formulation of a drug ondansetron to manage children suffering from diarrhea and vomiting

Intramuscular versus Oral Ondansetron for Management of Children with Acute Dehydrating Diarrhea and Vomiting â?? A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/023082
Enrollment
240
Registered
2020-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E860- Dehydration Health Condition 2: R197- Diarrhea, unspecified Health Condition 3: R111- Vomiting

Interventions

Intervention1: Intramuscular Ondansetron: 0.2 mg/kg, single dose, via intramuscular route Control Intervention1: Oral Ondansetron: 0.2mg/kg (0.5ml/kg of 2mg/5ml ondansetron syrup), single dose, via o

Sponsors

University College of Medical Sciences and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with acute diarrhea (duration <14 days) with some dehydration as per WHO criteria, and at least two reported episodes of non-bilious, non-bloody, vomiting within last 6 hours

Exclusion criteria

Exclusion criteria: 1. Severe malnutrition (weight for length / height 2. Conditions associated with edema (e.g. nephrotic syndrome, congestive heart failure) 3. Known hypersensitivity to ondansetron 4. Known cardiac disorder or previous history of arrhythmias 5. Unconscious or Convulsing 6. Presence of paralytic ileus or intestinal obstruction as evaluated clinically. 7. Children who have received any antiemetic or intravenous fluids within 24 hours before enrolment.

Design outcomes

Primary

MeasureTime frame
Failure of ORT (defined as persistence of signs of some dehydration after 4 hours of ORT or need for intravenous fluids at any time during oral rehydration therapy)Timepoint: 4 hours

Secondary

MeasureTime frame
1. Need for unscheduled intravenous fluids 2. Amount of ORS (mL/kg) ingested after 4 hours 3. Frequency of vomiting episodes in each group 4. Adverse effects 5. Caregiver satisfaction measured on a Likert scale Timepoint: 4 hours

Countries

India

Contacts

Public ContactDr Dheeraj Shah

University College of Medical Sciences and GTB Hospital, Delhi

shahdheeraj@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026